Education
About Us
Working with TipRanks
Follow Us
Omega Therapeutics (OMGAQ)
OTHER OTC:OMGAQ
See the Price Targets and Ratings of:
OMGAQ Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Raymond James
―
Hold
―
Downgraded
11/15/24
Omega downgraded to Market Perform from Outperform at Raymond JamesOmega downgraded to Market Perform from Outperform at Raymond James
Piper Sandler
$4
Buy
9900.00%
Upside
Assigned
11/15/24
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
H.C. Wainwright
$12
Buy
29900.00%
Upside
Reiterated
08/15/24
We value Omega Therapeutics using a discounted cash flow (DCF)-based methodology that yields a total firm value of $788M, which includes an enterprise value of $745M for solely the OTX-2002 and OTX-2101 candidates in solid tumors. Our assessment employs a 10% probability of approval for both these assets, given their early-stage status. We also utilize a 12% discount rate and 1% terminal growth rate, which we consider appropriate given the established nature of Omega's target markets as well as the plethora of candidates in the company's pipeline.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Raymond James
―
Hold
―
Downgraded
11/15/24
Omega downgraded to Market Perform from Outperform at Raymond JamesOmega downgraded to Market Perform from Outperform at Raymond James
Piper Sandler
$4
Buy
9900.00%
Upside
Assigned
11/15/24
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
H.C. Wainwright
$12
Buy
29900.00%
Upside
Reiterated
08/15/24
We value Omega Therapeutics using a discounted cash flow (DCF)-based methodology that yields a total firm value of $788M, which includes an enterprise value of $745M for solely the OTX-2002 and OTX-2101 candidates in solid tumors. Our assessment employs a 10% probability of approval for both these assets, given their early-stage status. We also utilize a 12% discount rate and 1% terminal growth rate, which we consider appropriate given the established nature of Omega's target markets as well as the plethora of candidates in the company's pipeline.
Best Analysts Covering Omega Therapeutics
Which Analyst Should I Follow If I Want to Buy OMGAQ and Sell After:
1 Month
xxx
Success Rate
3/10 ratings generated profit
Average Return
-6.05%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 30.00% of your transactions generating a profit, with an average return of -6.05% per trade.
3 Months
xxx
Success Rate
3/10 ratings generated profit
Average Return
-14.74%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 30.00% of your transactions generating a profit, with an average return of -14.74% per trade.
1 Year
Success Rate
0/10 ratings generated profit
Average Return
-73.44%
reiterated a buy rating 9 months ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -73.44% per trade.
2 Years
xxx
Success Rate
0/10 ratings generated profit
Average Return
-96.75%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -96.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OMGAQ Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Nov 24
Dec 24
Feb 25
Strong Buy
5
5
4
3
1
Buy
0
0
0
0
0
Hold
0
0
1
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
5
4
Each month's total comprises the sum of three months' worth of ratings.
OMGAQ Stock Forecast FAQ
What is OMGAQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is OMGAQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for OMGAQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OMGAQ a Buy, Sell or Hold?
Currently, no data Available
What is Omega Therapeutics’s price target?
Currently, no data Available
What do analysts say about Omega Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of OMGAQ?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.